Announcements Trials
Browse Landscape

Phase

Phase 2 59Phase NA 16Phase 1 14Phase 3 13Phase 1/2 9Phase EARLY_PHASE1 8Phase 2/3 3

Status

Completed 8Recruiting 5Unknown 3Active not recruiting 3Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 22Thoracic 11Breast 11Genitourinary 10Lymphoid 9Other hematologic neoplasm 7Head & Neck 7Sarcoma 4Gynecologic 4CNS 4Endocrine 3Dermatologic 3Tumor-Agnostic 2Myeloid 2Plasma cell 1Other solid neoplasm 1

Conditions

Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Neoplasm Metastasis 1Hyperaldosteronism 1Advanced Neuroendocrine Neoplasm 1Adrenal Gland Neoplasms 1Adenocarcinoma, Follicular 1

Interventions

lutetium Lu 177 dotatate 1Sodium Iodide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Active not recruiting × Endocrine × Clear all
NCT01398085 2026-05-07

IoN

University College, London

Phase 2/3 Active not recruiting
504 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT06100367 2025-12-02

11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

Changi General Hospital

Phase 2/3 Active not recruiting
100 enrolled
Endocrine

Adrenal Gland Neoplasms, Hyperaldosteronism, Neoplasm Metastasis

NCT06398444 2025-09-05

A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms

Sinotau Pharmaceutical Group

Phase 2/3 Active not recruiting
74 enrolled
Endocrine

Advanced Neuroendocrine Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡